Interaction of 21 benzodiazepines with the glycine receptor in the brainstem and spinal cord of rat have been evaluated in terms of their displacement of ['HIstrychnine The most prominent clinical actions of the benzodiazepines, a class of drugs including such widely used agents as diazepam (Valium®) and chlordiazepoxide (Librium®), are relief of anxiety, muscular relaxation, and amelioration of convulsive states. A variety of evidence suggests that these drugs enhance polysynaptic inhibitory processes in the spinal cord, brain stem, and thalamus (1). Many inhibitory processes in these areas are medicated by glycine-containing interneurons (2, 3). Recently we have identified specific binding of radiolabeled strychnine associated with glycine receptor sites in the mammalian spinal cord, brain stem and thalamus (4). The relative abilities of amino acids to mimic the neurophysiologic actions of glycine correlate with their affinities for these binding sites, and the regional distribution of specific strychnine binding in the central nervous system closely parallels the distribution of glycine as well as neurophysiological sensitivity to glycine (3, 5) . In the present study we have examined the relative affinities of a series of benzodiazepines for specific strychnine-binding sites in the brain stem, spinal cord, and thalamus of the rat and have correlated this data with the pharmacological actions of the benzodiazepines.
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MATERIALS AND METHODS
Strychnine was labeled by catalytic tritium exchange at New England Nuclear Corp. and purified as described preyously (4) . The specific activity of the labeled strychnine was 13 Ci/mmol, with concentrations determined by comparison with the ultraviolet absorption of standard solutions at 254 nm.
Tissue Preparation. Male Sprague-Dawley rats (100-150 g) were decapitated and the brainstems and spinal cords removed. Crude synaptic membrane fractions of these tissues were prepared by the differential centrifugation technique previously reported (4 (6) .
Thirteen of the benzodiazepines (Fig. 1 ) possess a common B-ring structure, except for variations in the X-substituent. Dreiding molecular models of glycine can be readily superimposed upon a portion of the B-ring of these 13 agents. By contrast, models of glycine cannot be as effectively superimposed upon the B-rings of the drugs shown in Fig. 2 . Interestingly, the drugs having the B-ring structure shown in Fig. 1 tend to be more potent than those having the variant structures shown in Fig. 2 , as indicated in Fig. 3 , where the latter are italicized. The mean ED50 for the drugs in Fig. 1 is significantly lower than that for the drugs in Fig. 2 (Fig. 4) . Displacement of [1H] strychnine by benzodiazepines has a Hill coefficient of 1.0, the same as for strychnine (Fig. 4) . This suggests that benzodiazepines interact with the strychnine rather than the glycine site of the receptor. (10) binding were performed as previously described. The rank order of potency of the benzodiazepines in inhibiting receptor binding was correlated with the rank order of potency of these drugs in a variety of pharmacological and behavioral tests (6) (2) (3) (4) (5) . It is conceivable that muscle relaxant actions involve an enhancement of glycine-mediated synaptic inhibition in the spinal cord, while antianxiety effects result from enhanced synaptic inhibition in the brain stem or higher centers. Influences of benzodiazepines on limbic system activity (6) might involve glycine receptors in limbic structures (4) or might result secondarily from effects on brainstem glycine receptors. The effects of benzodiazepines on seizure activity, both cortically and subcortically induced, may result from potentiation of inhibitory pathways from the brainstem reticular activating system. The concentration of benzodiazepine in the blood and central nervous system at pharmacologically active doses (8) 
